Clearmind Medicine Gross Profit

Clearmind Medicine (CMND) currently reports a gross profit of $-64K as of July 2026. That compares with $-24K in the prior-year period — down 167.5% year over year. That is below the Healthcare sector average of $66B. Use the charts on this page to explore Clearmind Medicine's gross profit history and peer comparisons.

Clearmind Medicine's gross profit decreased from $-24K to $-64K — a 167.5% year-over-year decrease (period ending July 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Clearmind Medicine's gross profit of $-64K is lower than the Healthcare sector average of $66B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Clearmind Medicine reported $-64K in gross profit as of July 2026. That compares with $-24K in the prior-year period — down 167.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current gross profit of $-64K, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $66B. From there, open related valuation or income-statement pages for Clearmind Medicine, and consider following CMND for alerts when major investors trade the stock.